scholarly journals Long‐term follow‐up of the DeKAF cross‐sectional cohort study

2019 ◽  
Vol 19 (5) ◽  
pp. 1432-1443 ◽  
Author(s):  
Arthur J. Matas ◽  
Ann Fieberg ◽  
Roslyn B. Mannon ◽  
Robert Leduc ◽  
Joe Grande ◽  
...  
Keyword(s):  
Cohort Study ◽  
Cross Sectional ◽  
Long Term Follow Up

scholarly journals Withdrawal notice: Long-term follow-up after abdominal cerclage: A population-based cohort study

2017 ◽  
Vol 210 ◽  
pp. R1
Author(s):  
Kirstine Sneider ◽  
Ole Bjarne Christiansen ◽  
Iben Blaabjerg Sundtoft ◽  
Jens Langhoff-Roos
Keyword(s):  
Cohort Study ◽  
Population Based ◽  
Long Term Follow Up

scholarly journals Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up

BMJ ◽  
2008 ◽  
Vol 337 (nov18 3) ◽  
pp. a2205-a2205 ◽  
Author(s):  
D. Tidemalm ◽  
N. Langstrom ◽  
P. Lichtenstein ◽  
B. Runeson
Keyword(s):  
Cohort Study ◽  
Suicide Attempt ◽  
Psychiatric Disorder ◽  
Long Term Follow Up ◽  
Swedish Cohort

scholarly journals Long‐term follow‐up of RET Y791F carriers in Denmark 1994‐2017: A National Cohort Study

2019 ◽  
Vol 119 (6) ◽  
pp. 687-693 ◽  
Author(s):  
Sanne Høxbroe Michaelsen ◽  
Marie Juul Ornstrup ◽  
Morten Møller Poulsen ◽  
Finn Noe Bennedbæk ◽  
Mette Gaustadnes ◽  
...  
Keyword(s):  
Cohort Study ◽  
Long Term Follow Up ◽  
National Cohort

scholarly journals Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study

2021 ◽  
Vol 13 (4) ◽  
pp. 888-901
Author(s):  
Nishat Jahan ◽  
Fahad Imtiaz Rahman ◽  
Poushali Saha ◽  
Sadia Afruz Ether ◽  
ASM Roknuzzaman ◽  
...  
Keyword(s):  
Side Effects ◽  
Rapid Development ◽  
Age Groups ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Post Vaccination ◽  
Long Term Follow Up ◽  
Larger Sample

In response to the raging COVID-19 pandemic, Bangladesh started its vaccine administration in early 2021; however, due to the rapid development and launch of the vaccines in the market, many people had concerns regarding the safety of these vaccines. The purpose of this study was to evaluate the side effects that were experienced by the Bangladeshi residents after receiving the first dose of the Oxford-AstraZeneca’s Covishield vaccine (ChAdOx1nCoV-19). The study was conducted using both online and printed questionnaires and the data were analysed using SPSS. The results included the responses of 474 vaccine recipients from March–April 2021. Pain at the site of injection, fever, myalgia, fatigue and headache were the most commonly reported symptoms, and the overall side effects were found to be significantly more prevalent in the younger population (p ≤ 0.05). These findings were consistent with the results indicated by the clinical trial of ChAdOx1nCoV-19. Logistic regression analysis further revealed that compared to people aged 70 years or above, the incidence of reported side effects was significantly higher in people aged 18–30 years (odds ratio (OR) = 8.56), 31–40 years, (OR = 5.05), 41–50 years (OR = 4.08), 51–60 years (OR = 3.77) and 61–70 years (OR = 3.67). In addition, a significantly higher percentage of female participants suffered from post-vaccination side effects compared to males (OR = 1.51). It was concluded that the Covishield vaccine was well-tolerated among people of different age groups. Nevertheless, further long-term follow-up study with a larger sample size is warranted to establish the long-term safety of the COVID-19 vaccine.

Long-term follow-up of a 10-month programme in curriculum development for medical educators: a cohort study

2008 ◽  
Vol 42 (7) ◽  
pp. 684-692 ◽  
Author(s):  
Aysegul Gozu ◽  
Donna M Windish ◽  
Amy M Knight ◽  
Patricia A Thomas ◽  
Ken Kolodner ◽  
...  
Keyword(s):  
Cohort Study ◽  
Curriculum Development ◽  
Long Term Follow Up ◽  
Medical Educators
Sign in / Sign up

Export Citation Format

Share Document